High-velocity nasal insufflation in dogs with left-sided congestive heart failure unresponsive to traditional oxygen therapy: a retrospective case series
Date
2025-05-09
Authors
Lane, Bailey
Walton, Rebecca A.
Blong, April E.
Hoen, Meredith ‘t
Tropf, Melissa A.
Masters, Allison K.
Major Professor
Advisor
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers
Abstract
Objective: To describe high–velocity nasal insufflation (HVNI) for managing dogs with left–sided congestive heart failure (L–CHF) failing traditional oxygen therapy (TOT). To secondarily evaluate complications based on retrospective evaluation of the record of HVNI and survival to discharge. Design: Retrospective case series from a university teaching hospital between August 2019 and October 2021. Animals: Twelve dogs diagnosed with L-CHF and managed with HVNI. Measurements and main results: Medical records were retrospectively reviewed for signalment, point-of-care diagnostics, and HVNI information. Nine dogs were diagnosed with myxomatous mitral valve disease, and three dogs were diagnosed with dilated cardiomyopathy. All dogs in this study required HVNI after failing TOT. Dogs were treated with HVNI for a median of 14 h (range 2–22 h). HVNI was successfully discontinued in 10 dogs (83%), all of which survived to discharge. Two dogs on HVNI were humanely euthanized, both of which were diagnosed with Stage D refractory CHF. No major complications of HVNI were noted in any dogs. Conclusion: HVNI is a potential method of escalating oxygen support for dogs in L-CHF who fail TOT. In this case series, all dogs in which HVNI was successfully discontinued survived to discharge.
Series Number
Journal Issue
Is Version Of
Versions
Series
Academic or Administrative Unit
Type
Article
Comments
This article is published as Lane, Bailey, Rebecca Walton, April Blong, Meredith t Hoen, Melissa Tropf, Jessica Ward, and Allison Masters. "High-velocity nasal insufflation in dogs with left-sided congestive heart failure unresponsive to traditional oxygen therapy: a retrospective case series." Frontiers in Veterinary Science 12: 1562633. doi: https://doi.org/10.3389/fvets.2025.1562633.
Rights Statement
© 2025 The Authors. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY).The use, distribution or reproduction
in other forums is permitted, provided the original author(s) and the copyright owner(s)
are credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.